Stille AB STIL.ST
Nasdaq Stockholm · Healthcare · Medical Instruments & Supplies
253.50 SEK
+0.8%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Stille
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 246 | 295 | 570 | 568 |
| EBITDA | 45 | 56 | 119 | 116 |
| Net income | 27 | 27 | 58 | 56 |
| Balance sheet | ||||
| Equity | 190 | 632 | 699 | 709 |
| Total debt | 71 | 63 | 63 | 123 |
| Cash | 37 | 241 | 158 | 119 |
| Net debt | 34 | −179 | −95 | 5 |
| Ratios and per share | ||||
| EBITDA margin | 18.2% | 19.0% | 20.9% | 20.4% |
| Profit margin | 11.1% | 9.0% | 10.2% | 9.8% |
| Return on equity | 14.4% | 4.2% | 8.3% | 7.9% |
| Earnings/share (SEK) | 5.45 | 5.31 | 6.48 | 6.20 |
| Book value/share (SEK) | 37.86 | 126.11 | 77.84 | 78.87 |
| Shares outstanding (M) | 5 | 5 | 9 | 9 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 40.9 |
| P/B | 3.2 |
| EV / EBITDA | 19.7 |
| Net debt / EBITDA | 0.0 |
| Return on equity | 7.9% |
| Profit margin | 9.8% |
| Beta 1Y | −0.04 |
| Revenue growth 1Y | −0.4% |
| Revenue CAGR 3Y | +32.1% |
| Earnings/share CAGR 3Y | +4.4% |
| ROE avg. 3Y | 6.8% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2023 | 1.80 |
| 2022 | 1.00 |
Not investment advice. Figures may contain errors from the data source.